These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31077585)

  • 1. Omega-3 polyunsaturated fatty acids: is their future VITALized or REDUCEd?
    Gajos G
    Cardiovasc Res; 2019 May; 115(6):e58-e60. PubMed ID: 31077585
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Tutor A; O'Keefe EL; Lavie CJ; Elagizi A; Milani R; O'Keefe J
    Prog Cardiovasc Dis; 2024; 84():19-26. PubMed ID: 38547956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids.
    Kris-Etherton PM; Richter CK; Bowen KJ; Skulas-Ray AC; Jackson KH; Petersen KS; Harris WS
    Methodist Debakey Cardiovasc J; 2019; 15(3):171-178. PubMed ID: 31687095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of omega-3 fatty acids on cardiovascular disease.
    Wang C; Chung M; Lichtenstein A; Balk E; Kupelnick B; DeVine D; Lawrence A; Lau J
    Evid Rep Technol Assess (Summ); 2004 Mar; (94):1-8. PubMed ID: 15133888
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
    Maki KC; Dicklin MR
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29973554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature.
    Colussi G; Catena C; Sechi LA
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):78-96. PubMed ID: 26206120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Fatty Acids and Cardiovascular Disease Prevention.
    Tomdio A; Ritchie M; Miller AC
    Am Fam Physician; 2019 Aug; 100(4):209-210. PubMed ID: 31414778
    [No Abstract]   [Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention.
    Chalupka S
    AAOHN J; 2009 Nov; 57(11):480. PubMed ID: 19968213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
    Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on omega-3 PUFAs in heart failure.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):345. PubMed ID: 22836158
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary cardiovascular prevention: omega-3 fatty acids ineffective.
    Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”.
    Hu FB; Manson JE
    Arch Intern Med; 2012 May; 172(9):694-6. PubMed ID: 22493410
    [No Abstract]   [Full Text] [Related]  

  • 15. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Siscovick DS; Barringer TA; Fretts AM; Wu JH; Lichtenstein AH; Costello RB; Kris-Etherton PM; Jacobson TA; Engler MB; Alger HM; Appel LJ; Mozaffarian D;
    Circulation; 2017 Apr; 135(15):e867-e884. PubMed ID: 28289069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease.
    von Schacky C
    Evid Based Med; 2013 Aug; 18(4):e33. PubMed ID: 23161504
    [No Abstract]   [Full Text] [Related]  

  • 17. Omega-3 Fatty Acid Supplements and Risk of CHD.
    Rosenberg K
    Am J Nurs; 2018 May; 118(5):69. PubMed ID: 29698285
    [No Abstract]   [Full Text] [Related]  

  • 18. Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery.
    Messori A; Fadda V; Maratea D
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):991-2. PubMed ID: 24041165
    [No Abstract]   [Full Text] [Related]  

  • 19. n-3 PUFAs and cardiovascular disease prevention.
    Manerba A; Vizzardi E; Metra M; Dei Cas L
    Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids and cardiovascular risk.
    Kruse LG; Ogletree RL
    J Miss State Med Assoc; 2013 Jun; 54(6):156-7. PubMed ID: 23991511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.